TMBR Timber Pharmaceuticals, Inc.

Timber Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases

$0.71  +0.01 (1.71%)
As of 10/25/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/04/2015
Outstanding shares:  36,659,685
Average volume:  943,900
Market cap:   $27,179,490
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    887080109
ISIN:        US8870801094
Valuation   (See tab for details)
PE ratio:   -19.16
PB ratio:   5.36
PS ratio:   39.92
Return on equity:   -24.95%
Net income %:   -175.35%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy